Pharma Intelligence is part of the Informa Intelligence Division of Informa PLC
This is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC's registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.
State of the Industry 2019:
KNect365 Life Sciences recently conducted a survey into the clinical trial industry at its most interesting point to date, as organisations are implementing new technologies and trends such as AI, virtual trials and wearables.
The final report, based on 214 responses, reveals unique insights into what current benefits and challenges companies are facing in the processes of applying these new approaches to therapeutic development. Citeline introduces the report, exploring what some of the key takeaways mean for the industry.
214 clinical trials professionals from within pharma and biotech (28%), CROs (29%), service providers, consultancies and medical device companies (26%), investigator sites (6%) and academia (4%) responded to the survey. The majority of respondents were from Europe (66%) followed by North America (17%) and Asia (13%).
In Vivo: strategic insights for life sciences decision-maker...
“Pipeline-in-a-pill” has increasingly entered the biopharma executive’s vernacular, denoting an attractive asset that has considerable sales potential owing to the number of discrete patient populations it can target. While the phrase or concept may be in vogue, in reality it is one of the many guises or iterations of lifecycle management.
Topics BioPharmaceutical Drug Pricing Drug Review Drug Development Landscape
Citeline, In Vivo: strategic insights for life sciences deci...
Months of pandemic-induced disruption to health care systems and freedom of movement undoubtedly carries a cost. For the biopharmaceutical industry, this can be mitigated by its essential role in providing therapeutic interventions and leading the fightback via prophylactic vaccines. This softens the blow somewhat, certainly compared to other industries that are fully exposed to COVID-19 headwinds.
Citeline
The clinical trial landscape continues to evolve as scientific breakthroughs and technological innovations emerge. Examine the state of Phase I–III clinical trials initiated in 2019 when you download the Annual Clinical Trials Roundup from Citeline’s Trialtrove, your trusted source for global clinical trials intelligence.
Topics Clinical Trials
Request a Trial
Whether you’re a small biotech start-up, research firm, generic manufacturer or a global pharmaceutical giant, you need focused, independent insight and opinion on market developments.
How can we help you?
Our team is always happy to hear from you. Please call us at:
Pharma Report Store
Have an immediate and specific information need?
Browse and buy from 1000s of analysis and research reports now:
The industry’s most trusted drug development database, Citeline's Pharmaprojects has been covering pharma R&D across global markets for 35+ years. With 68,000+ drug profiles including 15,000 drugs in active development, it’s the go-to resource for preclinical, clinical, and pipeline coverage, and lifecycle management tracking.
Trialtrove is the go-to resource for clinical trial research. Easily track your competitors' clinical R&D activity with expert insights and continually monitored trials.
Citeline Engage is our powerful new solution that combines our leading investigator engagement capability with real-world data to help you gather expert feedback on critical business topics, ignite awareness of your upcoming or ongoing trials, and recruit the right investigators for your clinical trials.
Looking for more products Product Finder
